Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2008 08:30 ET | Source: Adeona Pharmaceuticals, Inc.

Adeona Pharmaceuticals to Present At Rodman & Renshaw Healthcare Conference

ANN ARBOR, Mich., Nov. 4, 2008 (GLOBE NEWSWIRE) -- Adeona Pharmaceuticals, Inc. (AMEX:AEN), a late-stage specialty pharmaceutical company developing innovative candidates for the treatment of...
October 28, 2008 08:59 ET | Source: Adeona Pharmaceuticals, Inc.

Adeona Pharmaceuticals' Oral dnaJP1 Phase II Clinical Findings Presented At the American College of Rheumatology Annual Meeting

ANN ARBOR, Mich., Oct. 28, 2008 (GLOBE NEWSWIRE) -- Adeona Pharmaceuticals, Inc. (AMEX:AEN), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...
October 16, 2008 08:45 ET | Source: Adeona Pharmaceuticals, Inc.

Pipex Pharmaceuticals, Inc. Completes Corporate Name Change to Adeona Pharmaceuticals and Receives New Ticker Symbol

ANN ARBOR, Mich., Oct. 16, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (the "Company" or "Pipex") (AMEX:PP), a pharmaceutical company developing innovative late-stage oral drug candidates for...
October 07, 2008 08:29 ET | Source: Adeona Pharmaceuticals, Inc.

Pipex Pharmaceuticals' Oral Flupirtine Receives IRB Approval to Initiate Phase II Clinical Trial for Fibromyalgia

ANN ARBOR, Mich., Oct. 7, 2008 (GLOBE NEWSWIRE) -- Pipex Pharmaceuticals, Inc. (AMEX:PP), a specialty pharmaceutical company developing innovative late-stage drug candidates for the treatment of...